GlassScriptPhysician profile
Michael L Levin
NPI 1902906753
$14,214.15
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $2,179 · 2023: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $12,980.05 | 2019-2023 | Sunlenca |
| Viiv Healthcare Company | $260.70 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $160.14 | 2019-2020 | |
| Amgen INC. | $134.91 | 2019-2020 | |
| Dova Pharmaceuticals | $119.85 | 2019 | |
| Janssen Products, LP | $101.41 | 2019 | |
| Pfizer INC. | $60.12 | 2019 | |
| Novo Nordisk INC | $58.96 | 2019-2020 | |
| Mylan Institutional INC. | $49.88 | 2019 | |
| Janssen Biotech, INC. | $37.01 | 2019 | |
| Astellas Pharma US INC | $30.06 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.48 | 2019 | |
| Amarin Pharma, INC. | $23.30 | 2019 | |
| Allergan, INC. | $23.21 | 2019 | |
| Celgene Corporation | $19.71 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $19.35 | 2020 | |
| Horizon Therapeutics Plc | $18.75 | 2019 | |
| Theratechnologies INC. | $17.33 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.90 | 2019 | |
| Lilly USA, LLC | $15.06 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.87 | 2019 | |
| Hikma Pharmaceuticals USA | $14.32 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $12.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.